Individual variability plays a significant role in the response to dopamine antagonists. Factors such as age, gender, genetic polymorphisms, and concurrent medical conditions can influence both the efficacy and toxicity of these drugs. For example, older adults may be more susceptible to the sedative effects and orthostatic hypotension due to altered pharmacokinetics.
